XML 18 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities:    
Net income (loss) $ (7,126.0) $ 1,095.9
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 337.6 475.8
Impairment of goodwill, intangibles and other assets 9,248.1 85.0
Net gain from sale of businesses (489.3) (712.3)
Loss on extinguishment of debt   (1.9)
Deferred income taxes (1,193.1) (99.1)
Stock-based compensation expense 57.9 61.2
Other, net 2.9 8.3
Changes in operating assets and liabilities, excluding the effects of acquisitions and divestitures:    
Accounts receivable (122.4) 54.4
Inventories (262.3) (707.0)
Accounts payable (61.4) 136.1
Accrued liabilities and other (210.4) (420.2)
Net cash provided by (used in) operating activities 181.6 (23.8)
Cash flows from investing activities:    
Proceeds from sale of divested businesses 2,774.6 2,101.4
Acquisitions and acquisition-related activity   (634.3)
Capital expenditures (273.7) (292.9)
Other investing activities 58.4 9.2
Net cash provided by investing activities 2,559.3 1,183.4
Cash flows from financing activities:    
Net short-term debt (903.9) 686.3
Loss on extinguishment of debt   (34.2)
Payments on long-term debt (2.0) (1,159.8)
Repurchase of shares of common stock (511.1)  
Cash dividends (332.3) (317.1)
Payments to dissenting shareholders   (161.6)
Equity compensation activity and other, net (18.7) (19.5)
Net cash used in financing activities (1,768.0) (1,005.9)
Exchange rate effect on cash and cash equivalents (15.0) 51.1
Increase in cash and cash equivalents 957.9 204.8
Cash and cash equivalents at beginning of period 485.7 587.5
Cash and cash equivalents at end of period 1,443.6 792.3
Supplemental disclosures:    
Net cash provided by discontinued operating activities 11.3 91.4
Net cash provided by (used in) discontinued investing activities 2,659.8 (97.8)
Capital expenditures for discontinued operations $ (118.1) (97.0)
Common stock issued for Jarden Acquisition   $ 294.0